According to Regencell Bioscience's latest financial reports the company's current EPS (TTM) is -$0.11. In 2021 the company made an earnings per share (EPS) of -$0.11 a decrease over its 2020 EPS that were of -$0.06426.
Year | EPS | Change |
---|---|---|
2021 | -$0.11 | 65.78% |
2020 | -$0.06426 | 107.77% |
2019 | -$0.03093 |